Stock-Based Compensation and Stockholders' Equity - Schedule of Outstanding Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Number of Stock Option Awards
Beginning balance outstanding stock options (in shares)	2,704,862
Granted (in shares)	0
Exercises (issuance of shares)	(299,220)
Forfeitures/expirations (in shares)	(11,945)
Ending balance outstanding stock options (in shares)	2,393,697	2,704,862
Options exercisable (in shares)	2,393,697
Weighted- Average Exercise Price
Beginning balance (in USD per share)	$ 12.01
Granted (in USD per share)	0
Exercises (issuance of shares) (in USD per share)	8.25
Forfeitures/expirations (in USD per share)	13.56
Ending balance (in USD per share)	12.47	$ 12.01
Options exercisable (in USD per share)	$ 12.47
Weighted- Average Remaining Contractual Term (years)
Outstanding	3 years 9 months 3 days	4 years 7 months 6 days
Exercises (issuance of shares)	2 years 4 months 9 days
Forfeitures/expirations	3 years 7 months 28 days
Options exercisable	3 years 9 months 3 days
Aggregate Intrinsic Value
Outstanding stock option awards at January 1	$ 7,540
Granted	0
Exercises (issuance of shares)	1,994	$ 6,686	$ 2,444
Forfeitures/expirations	(22)
Outstanding stock option awards at December 31	(15,379)	7,540
Options exercisable as of December 31	(15,379)
Total grant-date fair value of options exercised	2,589	4,499	1,488
Total grant-date fair value of options vested	$ 0	$ 5,063	$ 13,213
Weighted-average grant-date fair value per share of options exercised	$ 8.65	$ 7.44	$ 6.87